IMMUSMOL
ImmuSmol sells validated primary antibodies, for small molecule detection and visualization in cells and tissues. Their R and D activities also involve a network of scientific consultants and collaborators, bringing their insights into areas such as chemistry, immunology, oncology, and neuroscience.
IMMUSMOL
Industry:
Biotechnology Health Diagnostics Neuroscience Therapeutics
Founded:
2012-01-01
Address:
Bordeaux, Aquitaine, France
Country:
France
Website Url:
http://www.immusmol.com
Total Employee:
11+
Status:
Active
Contact:
+33 0 5 6431 1170
Email Addresses:
[email protected]
Technology used in webpage:
Wordpress Plugins WooCommerce Pixel Manager By Woopt
Official Site Inspections
http://www.immusmol.com Semrush global rank: 5.12 M Semrush visits lastest month: 1.59 K
- Host name: 193.203.190.116
- IP address: 193.203.190.116
- Location: Germany
- Latitude: 51.2993
- Longitude: 9.491
- Timezone: Europe/Berlin

More informations about "ImmuSmol"
Immusmol I Antibodies & ELISA kits for Small Molecules
Sep 22, 2020 Based on its range of anti-small molecule antibodies, ImmuSmol also offers ELISA kits for the detection of neurotransmitters, kynurenines, catecholamines, and arginine โฆSee details»
ImmuSmol - Crunchbase Company Profile & Funding
ImmuSmol sells validated primary antibodies, for small molecule detection and visualization in cells and tissues. Their R and D activities also involve a network of scientific consultants and โฆSee details»
Immusmol - LinkedIn
Immusmol | 1,405 followers on LinkedIn. The clear path to small molecule visualization & quantification | Over the past decade, Immusmol specialized in the development of antibodies โฆSee details»
ImmuSmol - Overview, News & Similar companies | ZoomInfo.com
ImmuSmol is a biotech company specializing in the development of small molecule antibodies for research, diagnostic, theranostic and therapeutic ap plications. Besides our pipeline of โฆSee details»
ImmuSmol Company Profile - Office Locations, Competitors ... - Craft
ImmuSmol is a company that develops small molecule antibodies for research, diagnostics, and therapy. It also delivers custom services helping to raise antibodies against a range of targets, โฆSee details»
Immusmol SAS - Drug pipelines, Patents, Clinical trials - Synapse
May 7, 2025 100 Clinical Results associated with Immusmol SAS. Login to view more data. 0 Patents (Medical) associated with Immusmol SAS. Login to view more data. 100 Deals โฆSee details»
Immusmol โข La French Tech Bordeaux
Immusmol est une biotech qui permet aux scientifiques de visualiser et de quantifier des petites molécules dans des échantillons biologiques, de manière simple, rapide, et fiable. Spécialiste โฆSee details»
ImmuSmol SAS - CMOCRO - Domain Name
ImmuSmol SAS, a small molecule antibody company, specializes in the development of small molecule antibodies for research, diagnostic, theranostic, and therapeutic applications. The โฆSee details»
Contact us - ImmuSmol
Mar 21, 2025 181 Rue de Saint- Genès, 33000 Bordeaux, FranceSee details»
ImmuSmol SAS - Enzo
Immusmol: the Small Molecule Antibody Company Search Products Keep up-to-date https://www.immusmol.com Centro de Apoyo a la Innovación Tecnológica(CAIT)UPMCampus โฆSee details»
Immusmol | ARP American Research Products, Inc.
Immusmol: the Small Molecule Antibody Company Founded in 2012 by immunologist Dr Alban Bessede, ImmuSmol aims at becoming a natural choice for small molecule antibodies. โฆSee details»
ImmuSmol - VentureRadar
ImmuSmol designs and develops antibodies capable of targeting low molecular weight entities (900 Da). Amino acids, lipids, saccharids, toxins, drugs, โฆ virtually any small molecule can โฆSee details»
ImmuSmol 2025 Company Profile: Valuation, Funding & Investors
ImmuSmol General Information Description. Developer of antibodies intended for staining applications for lab tests and immunoassay development. The company's product target small โฆSee details»
ImmuSmol Company Profile | Management and Employees List
ImmuSmol is a biotech company specializing in the development of small molecule antibodies for research, diagnostic, theranostic and therapeutic applications. Besides our pipeline of โฆSee details»
Services - ImmuSmol
Immusmol SAS 229 Cours de lโArgonne 33 000 Bordeaux, France +33 (0) 5 6431 1170. We use cookies on our website to give you the most relevant experience by remembering your โฆSee details»
ImmuSmol - sobekbio.com
ImmuSmol aims to become a natural choice for small molecule antibodies development, collaborating with a worldwide network of scientists. ImmuSmolโs focus: validated tools for โฆSee details»
Knowledge base - Immusmol
The clear path to small molecule visualization & quantification Contact. About Us. Company; Services; News; CareersSee details»
International Distributor Network I Immusmol
Mar 27, 2022 Stay up to date with our latest news by entering your email belowSee details»
IS 001 - AdisInsight - Springer
11 Sep 2023 Preclinical development is ongoing in Cancer in France (Parenteral) (ImmuSmol website, September 2023) 28 Aug 2020 No recent reports of development identified for โฆSee details»
Launch of Explicyte Immuno-Oncology! - Immusmol
Mar 24, 2016 ImmuSmol is launching today a range of preclinical services in the field of cancer immunotherapy under the brand Explicyte Immuno-Oncology.. Explicyte Immuno-Oncology โฆSee details»